COCH
Envoy Medical Inc.
NASDAQ: COCH · HEALTHCARE · MEDICAL DEVICES
$0.68
+0.47% today
Updated 2026-04-30
Market cap
$51.86M
P/E ratio
—
P/S ratio
215.20x
EPS (TTM)
$-1.23
Dividend yield
—
52W range
$0 – $2
Volume
0.3M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
6.0
Growth
B5.0
Quality
C+3.0
Profitability
D6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$2.50
+267.65%
12-Month target
—
—
Intrinsic (DCF)
$1.45
Margin of safety
+54.50%
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 78.60% QoQ
+ 54.50% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-5.86M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $237000.00 | $316000.00 | $225000.00 | $241000.00 | $241000.00 |
| Net income | $-15.92M | $-29.92M | $-20.80M | $-23.76M | $-6.59M |
| EPS | — | — | — | — | $-1.23 |
| Free cash flow | $-9.02M | $-17.24M | $-18.93M | $-18.38M | $-5.86M |
| Profit margin | -6,718.57% | -9,468.99% | -9,242.22% | -9,857.26% | — |
Peer comparison
Smart narrative
Envoy Medical Inc. trades at $0.68. Our Smart Value Score of 26/100 indicates the stock is weak. TTM revenue stands at $241000.00. Our DCF model estimates intrinsic value at $1.45.
Frequently asked questions
What is Envoy Medical Inc.'s stock price?
Envoy Medical Inc. (COCH) trades at $0.68.
Is Envoy Medical Inc. overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell). DCF value $1.45.
What is the price target of Envoy Medical Inc. (COCH)?
The analyst target price is $2.50, representing +267.6% upside from the current price of $0.68.
What is the intrinsic value of Envoy Medical Inc. (COCH)?
Based on our DCF model, intrinsic value is $1.45, a +54.5% margin of safety versus $0.68.
What is Envoy Medical Inc.'s revenue?
TTM revenue is $241000.00.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio215.20x
ROE—
Beta2.05
50D MA$0.71
200D MA$0.91
Shares out0.08B
Float0.05B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—